Specifically, SOX10 has demonstrated greater expression stability compared to S100 in melanoma diagnostics, while Melan-A may be negative in amelanotic variants, highlighting the need for panel-based interpretation rather than reliance on individual markers [17,32]. The gene discussed is SOX10; the disease is melanoma.